Sepsis Diagnostics Market valued at $510 million (2021), is set to witness a healthy growth of 9%

Development of rapid diagnostic tests/point-of-care techniques, growing cases of sepsis & hospital-acquired infections, and favorable initiatives & funding for sepsis-related research are driving the growth of the Sepsis Diagnostics Market.
 
BRUSSELS - April 14, 2022 - PRLog -- Sepsis is a life-threatening medical emergency. It is a body's reaction to infection that may lead to a systemic inflammatory reaction, tissue damage, and ultimately organ dysfunction and/or failure.

As per WHO, globally, sepsis affects around 49 million people each year. Early diagnosis of sepsis is critical for patient outcomes. However, diagnosing sepsis is not an easy task as there is no particular symptom or sign that are directly related to the disease.

Development of Rapid Diagnostic Tests/Point-of-Care Techniques set to drive the Sepsis Diagnostics Market Growth

Currently, clinicians possess limited technology needed to conduct multiplexed and fully quantitative diagnostic tests at the point of care with high sensitivity. Citing the need for rapid diagnostic tests, several research universities and product manufacturers are developing innovative rapid diagnostic tests/point-of-care techniques.

For instance,
  • Researchers at the University of Strathclyde have developed an innovative, low cost test for early diagnosis of sepsis. The experimental device analyzes patient's blood and provides results in just 2.5 minutes compared to current testing methods for sepsis which takes up to 72 hours.

"With sepsis, timing is the key. Advancements in diagnostic speed, range, and accuracy are critical for addressing the continued rise in sepsis cases and deaths. Advent of new rapid diagnostic tests for sepsis can save thousands of lives." - Senior Director, Leading In-Vitro Diagnostics Manufacturer, United States

Favorable Initiatives and Funding for Sepsis Research

In an endeavor to shape the future of sepsis research, (NIGMS) intends to use the NIH SBIR/STTR program to support preclinical and clinical sepsis studies to develop improved diagnostic tools and therapies.

Diagnostics companies are also continuously securing funding to develop rapid sepsis diagnostic tests.

Competitive Landscape Analysis: Global Sepsis Diagnostics Market

The global Sepsis Diagnostics market is marked by the presence of both established players such as bioMérieux, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation and innovative firms such as Seegene Inc., Axis-Shield Diagnostics, Immunexpress, and others.

Get Customized Report on Sepsis Diagnostics Market @ https://meditechinsights.com/sepsis-diagnostics-market/

Contact
Medi-Tech Insights
aves.s@meditechinsights.com
32 498868079
End
Email:***@meditechinsights.com Email Verified
Tags:Sepsis Diagnostics Market
Industry:Health
Location:Brussels - Brussels - Belgium
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Medi-Tech Insights News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share